title: A summary statistic approach to sequence variation in noncoding regions of six schizophrenia-associated gene loci.
abstract: In order to explore the role of noncoding variants in the genetics of schizophrenia, we sequenced 27 kb of noncoding DNA from the gene loci RAC-alpha serine/threonine-protein kinase (AKT1), brain-derived neurotrophic factor (BDNF), dopamine receptor-3 (DRD3), dystrobrevin binding protein-1 (DTNBP1), neuregulin-1 (NRG1) and regulator of G-protein signaling-4 (RGS4) in 37 schizophrenia patients and 25 healthy controls. To compare the allele frequency spectrum between the two samples, we separately computed Tajima's D-value for each sample. The results showed a smaller Tajima's D-value in the case sample, pointing to an excess of rare variants as compared to the control sample. When randomly permuting the affection status of sequenced individuals, we observed a stronger decrease of Tajima's D in 2400 out of 100,000 permutations, corresponding to a P-value of 0.024 in a one-sided test. Thus, rare variants are significantly enriched in the schizophrenia sample, indicating the existence of disease-related sequence alterations. When categorizing the sequenced fragments according to their level of human-rodent conservation or according to their gene locus, we observed a wide range of diversity parameter estimates. Rare variants were enriched in conserved regions as compared to nonconserved regions in both samples. Nevertheless, rare variants remained more common among patients, suggesting an increased number of variants under purifying selection in this sample. Finally, we performed a heuristic search for the subset of gene loci, which jointly produces the strongest difference between controls and cases. This showed a more prominent role of variants from the loci AKT1, BDNF and RGS4. Taken together, our approach provides promising strategy to investigate the genetics of schizophrenia and related phenotypes.
authors.affiliation: Institute of Human Genetics, University of Bonn, Bonn, Germany.
authors.forename: Jane
authors.initials: J
authors.lastname: Winantea
authors.forename: My Ngo
authors.initials: MN
authors.lastname: Hoang
authors.forename: Stefanie
authors.initials: S
authors.lastname: Ohlraun
authors.forename: Marcella
authors.initials: M
authors.lastname: Rietschel
authors.forename: Sven
authors.initials: S
authors.lastname: Cichon
authors.forename: Peter
authors.initials: P
authors.lastname: Propping
authors.forename: Markus M
authors.initials: MM
authors.lastname: Nöthen
authors.forename: Jan
authors.initials: J
authors.lastname: Freudenberg
authors.forename: Yun
authors.initials: Y
authors.lastname: Freudenberg-Hua
mesh_terms: D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics; D016022:Case-Control Studies; D021901:DNA, Intergenic; D003627:Data Interpretation, Statistical; D014644:Genetic Variation; D006801:Humans; D020641:Polymorphism, Single Nucleotide; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics; D020710:RGS Proteins / Q000235:genetics; D012559:Schizophrenia / Q000235:genetics*
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D021901:DNA, Intergenic; D020710:RGS Proteins; C098799:RGS4 protein; C494918:AKT1 protein, human; D051057:Proto-Oncogene Proteins c-akt